Trifluridine/tipiracil (FTD/TPI) in extensively pre-treated metastatic colorectal cancer (mCRC) patients: Evaluation of prognostic subgroups of the TALLISUR study

被引：0
|
作者：
Karthaus, Meinolf
Weiss, Lena
Riera-Knorrenschild, Jorge
Kretzschmar, Albrecht
Welslau, Manfred
Vehling-Kaiser, Ursula
Pelz, Henning
Ettrich, Thomas Jens
Held, Swantje
Kehrmann, Linde
Hess, Juergen
Reislaender, Timo
Heinemann, Volker
机构：
[1] Munich Hosp Neuperlach, Dept Hematol & Oncol, Munich, Germany
[2] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Med 3, Munich, Germany
[3] Univ Klinikum Marburg, Klin Innere Med, Marburg, Germany
[4] Hematol & Oncol Practice MVZ Mitte, Leipzig, Germany
[5] Zentrum Integrat Onkol, Glarus, Switzerland
[6] Zentrum Integrat Onkol, Leipzig, Germany
[7] Praxis Aschaffenburg, Aschaffenburg, Germany
[8] Praxis Vehling Kaiser, Landshut, Germany
[9] Ambulantes Therapiezentrum Haematol & Onkol, Offenburg, Germany
[10] Ulm Univ, Ulm, Germany
[11] Clinassess Inc, Leverkusen, Germany
[12] Servier, Munich, Germany
[13] Servier Deutschland GmbH, Munich, Germany
[14] Univ Munich, Munich, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3556
引用
收藏
页数：1
相关论文
共 50 条
  • [1] TALLISUR Phase IV study of trifluridine/tipiracil (FTD/TPI) in patients with pre-treated metastatic Colorectal Cancer (mCRC) - subgroup analysis
    Karthaus, M.
    Weiss, L.
    Riera-Knorrenschild, J.
    Kretschmar, A.
    Welslau, M.
    Vehling-Kaiser, U.
    Pelz, H.
    Ettrich, T.
    Held, S.
    Klein, A.
    Hess, J.
    Reislaender, T.
    Heinemann, V.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 160 - 160
  • [2] Trifluridine/tipiracil (FTD/TPI) in metastatic colorectal cancer treatment
    Michel, Patryk S.
    Jankowski, Marek
    Sigorski, Dawid
    Kubiatowski, Tomasz
    ONCOLOGY IN CLINICAL PRACTICE, 2024, 20 (06):
  • [3] Real-world adherence in patients with metastatic colorectal cancer (mCRC) treated with trifluridine/tipiracil (FTD/TPI) or regorafenib (REG).
    Patel, Anuj K.
    Barghout, Victoria
    Yenikomshian, Mihran Ara
    Germain, Guillaume
    Jacques, Philippe
    Laliberte, Francois
    Duh, Mei Sheng
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (30)
  • [4] Trifluridine/tipiracil (FTD/TPI) and regorafenib (REG) in patients with metastatic colorectal cancer (mCRC): A single institution retrospective study
    Patel, Anuj K.
    Ng, Kimmie
    Duh, Mei Sheng
    Barghout, Victoria E.
    Lynn Huynh
    Yenikomshian, Mihran Ara
    Sharperson, Camara
    Brais, Lauren K.
    Fuchs, Charles S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [5] Trifluridine/tipiracil plus bevacizumab (FTD/TPI plus BEV) and trifluridine/tipiracil (FTD/TPI) monotherapy in metastatic colorectal cancer (mCRC): Results of a meta-analysis.
    Yoshino, Takayuki
    Taieb, Julien
    Andre, Thierry
    Kuboki, Yasutoshi
    Pfeiffer, Per
    Kumar, Amit
    Hochster, Howard S.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [6] Quality of life data from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: results of the TALLISUR study
    Karthaus, M.
    Kretzschmar, A.
    Welslau, M.
    Riera-Knorrenschild, J.
    Kaiser, F.
    Pelz, H.
    Ettrich, T.
    Lindig, U.
    Schulz, H.
    von Weikersthal, Fischer L.
    Kisro, J.
    de Wit, M.
    Wiebe, S.
    Koenigsmann, M.
    Mahlberg, R.
    Fuxius, S.
    Stehle, I
    Kubicka, S.
    Schuler, M. K.
    Schnoy, E.
    Ruessel, J.
    Graefe, T.
    Mayer, F.
    Berres, M. L.
    Kubin, T.
    Heinemann, V
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 219 - 219
  • [7] Trifluridine/tipiracil (FTD/TPI) and regorafenib in older patients with metastatic colorectal cancer
    Victorino, Ana Paula Ornellas S.
    Meton, Fernando
    Mardegan, Luciana
    Festa, Juliana
    Piranda, Diogo N.
    Araujo, Kelly Borges
    JOURNAL OF GERIATRIC ONCOLOGY, 2023, 14 (04)
  • [8] Subgroup analyses from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: results of the TALLISUR trial
    Karthaus, Meinolf
    Heinemann, Volker
    Riera-Knorrenschild, Jorge
    Kretzschmar, Albrecht
    Welslau, Manfred
    Kaiser, Ulrich
    Pelz, Henning
    Ettrich, Thomas J.
    Held, Swantje
    Kehmann, Linde
    Hess, Juergen
    Reislaender, Timo
    Weiss, Lena
    BMC CANCER, 2024, 24 (01)
  • [9] Safety of trifluridine/tipiracil (FTD/TPI) in elderly patients with metastatic colorectal cancer.
    Mayer, Robert J.
    Hochster, Howard S.
    Cohen, Steven J.
    Winkler, Robert
    Makris, Lukas
    Grothey, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [10] G-CSF secondary prophylaxis in patients (pts) with metastatic colorectal cancer (mCRC) treated with trifluridine/tipiracil (FTD/TPI): The GERCOR LONGBOARD study
    Bachet, J-B.
    Bouche, O.
    Trouilloud, I.
    Larnicol, M. L. Garcia
    Vernerey, D.
    Boisson, C.
    Hautefeuille, V.
    Laly, M.
    Rinaldi, Y.
    Fenioux, C.
    Smith, D.
    Desrame, J.
    Lecaille, C.
    Chibaudel, B.
    Wagner, J-P.
    Texereau, P.
    Vienot, A.
    Tougeron, D.
    Borg, C.
    ANNALS OF ONCOLOGY, 2024, 35 : S447 - S447
12345